Durata Therapeutics, Inc. | TalkMarkets | Page 1
Sign In
Sign Up
Sign up with:
×
Home
My Dashboard
Portfolio
Social
My Network
Education
Stocks
Keywords
Contributors
Users
No data available
No data available
Articles
Chart
SEC Fillings
Ownership
Earnings
Latest Articles
About This Stock
More About This Stock
Actavis Rumored To Be Close To Acquiring Allergan
Article By:
Zacks Investment Research
Monday, November 17, 2014 10:40 AM EDT
As per the sources, Actavis has agreed to pay $215 to $220 per share for the Botox maker.
In this article:
AGN
,
VRX
,
ZTS
,
ACT
,
DRTX
Read
Latest Tweets for $DRTX
No tweets yet!
PARTNER HEADLINES
$DRTX
Comments
Status Updates
×
